Loss of bax (reflecting the in vivo situation of human breast cancer patients) may disrupt c-Myc-induced apoptotic programs in mammary epithelial cells and has the potential to diminish the tumour suppressive activity of c-Myc-induced apoptosis. Here, BAX is linked to breast carcinoma.